3McClintockB. The origin and behavior of mutableloei in maize[J].Proe Natl Aead Sci U S A,1950,(06):344-355.
4Bestor T H. Transposons reanimated in mice[J].Cell,2005,(03):322-325.doi:10.1016/j.cell.2005.07.024.
5Horie K,Kuroiwa A,Ikawa M. Efficient chromosomal transposition of a Tcl/mariner-like transposon sleeping beauty inmice[J].Proceedings of the National Academy of Sciences(USA),2001,(16):9191-9196.doi:10.1073/pnas.161071798.
6Izsvak Z,Chuah M K,Vandendriessche T. Efficient stable gene transfer into human cells by the Sleeping Beauty transposonvectors[J].Methods:A Companion to Methods in Enzymology,2009,(03):287-297.
7Ivics Z,Katzer A,Stuwe E E. Targeted Sleeping Beautytransposition in human cells[J].Molecular Therapy,2007,(06):1137-1144.
8da Fonseca EL,Freitas Fdos S,de Amorim JC. Detection of new art-4 and arr-5 gene cassettes in clinical Pseudomonas aerugi-nosa and Klebsiella pneumoniae strains from Brazil[J].Antimicrob A-gents Chemother,2008,(05):1865-1867.doi:10.1128/AAC.00017-08.
9Urschitz J,Kawasumi M,Owens J. Helper-independent piggyBac plasmids for gene delivery approaches:strategies for avoiding potential genotoxic effects[J].Proceedings of the National Academy of Sciences(USA),2010,(18):8117-8122.doi:10.1073/pnas.1003674107.
10Izsvak Z,Chuah M K,Vandendriessche T. Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors[J].Methods:A Companion to Methods in Enzymology,2009,(03):287-297.doi:10.1016/j.ymeth.2009.07.001.
二级参考文献26
1Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study [ J]. Lancet Infect Dis. 2010 Aug 10. [ Epub ahead of print].
2Livermore DM , Hawkey PM . CTX--M : changing the face of ESBLs in the UK [J]. Antimicrob Chemother,2005,56(3) :451 -454.
3Dubois V, Arpin C, Dupart V, et al. Beta - lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice ( community and private healthcare centres) [J]. J Antimicrob Chemother. 2008 Aug;62(2) :316 -23.
4Wachino JI, Kurokawa H , Suzuki S ,et al. Horizontal transfer of blaCM Y--beating plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepimehydrolyzingCMY-19 [J]. Antimierob Agents Cbemotber,2006,50(2) :534-541.
6Paix? o L, Rodrigues L, Couto I, Martins M, Femandes P, de Carvalho CC, Monteiro GA,. Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli [ J]. Biol Eng. 2009 Oct 16; 3:18.
7Philippon A, Arlt G, Jaeoby G A, et al. Plasmid - determined AmpC type laetamases [J]. Antimierob Agents Chemother,2002,46(1) :1 - 11.
8Maniati M, lkonomidis A, Mantzana P, et al.A highly carbapenem - resistant Pseudomonas aeruginosa isolate with a novel blaVIM -4/ blaP1 b integron overexpresses two efflux pumps and lacks OprD [ J] . J Antimicrob Chemother,2007,60 ( 1) :132 - 135.
9Zhao WH, Chen G, Ito R, et al. Relevance of resistance levels to carbapenems and integron - borne blalMP - 1, blalMP -7, blalMP - 10 and blaVIM - 2 in clinical isolates of Pseudomonas aemginosa [ J]. J Med Microbiol. 2009,58 ( Pt 8 ) : 1080 - 1085.
10Navon - Venezia S, Chmelnitsky I, Leavitt A, et al. Dissemination of the CTX - M - 25 family beta - lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX - M -41 in Proteus mirabilis in Israel [ J]. J Antimicrob Chemother. 2008,62 ( 2 ) :289 - 295.
